Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Association of genetic variants in the calcium-sensing receptor with risk of colorectal adenoma.

Peters U, Chatterjee N, Yeager M, Chanock SJ, Schoen RE, McGlynn KA, Church TR, Weissfeld JL, Schatzkin A, Hayes RB.

Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2181-6.

2.

Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk.

Peters U, Hayes RB, Chatterjee N, Shao W, Schoen RE, Pinsky P, Hollis BW, McGlynn KA; Prostate, Lung, Colorectal and Ovarian Cancer Screening Project Team..

Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):546-52.

3.

Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma.

Peters U, Chatterjee N, Hayes RB, Schoen RE, Wang Y, Chanock SJ, Foster CB.

Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1144-54. doi: 10.1158/1055-9965.EPI-07-2947.

4.

Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas.

Peters U, McGlynn KA, Chatterjee N, Gunter E, Garcia-Closas M, Rothman N, Sinha R.

Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1267-74.

5.

Calcium, vitamin D, and risk for colorectal adenoma: dependency on vitamin D receptor BsmI polymorphism and nonsteroidal anti-inflammatory drug use?

Boyapati SM, Bostick RM, McGlynn KA, Fina MF, Roufail WM, Geisinger KR, Wargovich M, Coker A, Hebert JR.

Cancer Epidemiol Biomarkers Prev. 2003 Jul;12(7):631-7.

6.

Dietary intake of folate and riboflavin, MTHFR C677T genotype, and colorectal adenoma risk: a Dutch case-control study.

van den Donk M, Buijsse B, van den Berg SW, Ocké MC, Harryvan JL, Nagengast FM, Kok FJ, Kampman E.

Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1562-6.

7.

Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma.

Huang WY, Chatterjee N, Chanock S, Dean M, Yeager M, Schoen RE, Hou LF, Berndt SI, Yadavalli S, Johnson CC, Hayes RB.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):152-7.

8.

GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma.

Moore LE, Huang WY, Chatterjee N, Gunter M, Chanock S, Yeager M, Welch B, Pinsky P, Weissfeld J, Hayes RB.

Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1823-7.

9.

XRCC1 and XRCC3 polymorphisms and their role as effect modifiers of unsaturated fatty acids and antioxidant intake on colorectal adenomas risk.

Stern MC, Siegmund KD, Corral R, Haile RW.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):609-15.

10.

Insulin resistance-related genes and advanced left-sided colorectal adenoma.

Gunter MJ, Hayes RB, Chatterjee N, Yeager M, Welch R, Schoen RE, Yakochi L, Schatzkin A, Peters U.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):703-8.

11.

Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk.

Huang WY, Berndt SI, Kang D, Chatterjee N, Chanock SJ, Yeager M, Welch R, Bresalier RS, Weissfeld JL, Hayes RB.

Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):306-11.

12.

Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas.

Giovannucci E, Chen J, Smith-Warner SA, Rimm EB, Fuchs CS, Palomeque C, Willett WC, Hunter DJ.

Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):970-9.

13.

Calcium intake and colorectal adenoma in a US colorectal cancer early detection program.

Peters U, Chatterjee N, McGlynn KA, Schoen RE, Church TR, Bresalier RS, Gaudet MM, Flood A, Schatzkin A, Hayes RB.

Am J Clin Nutr. 2004 Nov;80(5):1358-65.

14.

APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma.

Tranah GJ, Giovannucci E, Ma J, Fuchs C, Hunter DJ.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):863-70.

15.

High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program.

Peters U, Chatterjee N, Church TR, Mayo C, Sturup S, Foster CB, Schatzkin A, Hayes RB.

Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):315-20.

16.

The methylenetetrahydrofolate reductase 677C-->T polymorphism and distal colorectal adenoma risk.

Levine AJ, Siegmund KD, Ervin CM, Diep A, Lee ER, Frankl HD, Haile RW.

Cancer Epidemiol Biomarkers Prev. 2000 Jul;9(7):657-63.

17.

Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction?

Ulrich CM, Kampman E, Bigler J, Schwartz SM, Chen C, Bostick R, Fosdick L, Beresford SA, Yasui Y, Potter JD.

Cancer Epidemiol Biomarkers Prev. 1999 Aug;8(8):659-68.

18.

Folate intake, MTHFR C677T polymorphism, alcohol consumption, and risk for sporadic colorectal adenoma (United States).

Boyapati SM, Bostick RM, McGlynn KA, Fina MF, Roufail WM, Geisinger KR, Hebert JR, Coker A, Wargovich M.

Cancer Causes Control. 2004 Jun;15(5):493-501.

PMID:
15286469
19.

Dietary intake of heterocyclic amines, meat-derived mutagenic activity, and risk of colorectal adenomas.

Sinha R, Kulldorff M, Chow WH, Denobile J, Rothman N.

Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):559-62.

20.

Diet and risk of colorectal adenomas: macronutrients, cholesterol, and fiber.

Sandler RS, Lyles CM, Peipins LA, McAuliffe CA, Woosley JT, Kupper LL.

J Natl Cancer Inst. 1993 Jun 2;85(11):884-91.

PMID:
8388061

Supplemental Content

Support Center